End-of-day quote
Shenzhen S.E.
23:00:00 28/04/2024 BST
|
5-day change
|
1st Jan Change
|
26
CNY
|
+5.48%
|
|
+7.39%
|
-11.71%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
4,910
|
6,727
|
8,034
|
7,089
|
-
|
-
|
Enterprise Value (EV)
1 |
4,910
|
6,727
|
8,034
|
7,089
|
7,089
|
7,089
|
P/E ratio
|
23.6
x
|
25.9
x
|
29.2
x
|
16.5
x
|
12
x
|
9.59
x
|
Yield
|
-
|
1.95%
|
1.7%
|
1.69%
|
2.29%
|
-
|
Capitalization / Revenue
|
-
|
5.51
x
|
5.83
x
|
3.07
x
|
2.38
x
|
1.84
x
|
EV / Revenue
|
-
|
5.51
x
|
5.83
x
|
3.07
x
|
2.38
x
|
1.84
x
|
EV / EBITDA
|
-
|
23.7
x
|
24.1
x
|
14.7
x
|
10.7
x
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
3.53
x
|
3.97
x
|
2.02
x
|
2.05
x
|
1.32
x
|
Nbr of stocks (in thousands)
|
273,987
|
273,337
|
272,791
|
272,659
|
-
|
-
|
Reference price
2 |
17.92
|
24.61
|
29.45
|
26.00
|
26.00
|
26.00
|
Announcement Date
|
28/04/22
|
17/04/23
|
18/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,220
|
1,378
|
2,311
|
2,981
|
3,849
|
EBITDA
1 |
-
|
283.5
|
333.7
|
483.5
|
662
|
-
|
EBIT
1 |
-
|
292.2
|
296.9
|
496
|
662.5
|
830.4
|
Operating Margin
|
-
|
23.95%
|
21.54%
|
21.46%
|
22.22%
|
21.57%
|
Earnings before Tax (EBT)
1 |
-
|
291.4
|
296.2
|
495.7
|
661.9
|
829.9
|
Net income
1 |
209.9
|
261.7
|
275.6
|
433.4
|
594
|
743.3
|
Net margin
|
-
|
21.45%
|
20%
|
18.75%
|
19.92%
|
19.31%
|
EPS
2 |
0.7600
|
0.9500
|
1.010
|
1.580
|
2.163
|
2.710
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
0.4800
|
0.5000
|
0.4400
|
0.5950
|
-
|
Announcement Date
|
28/04/22
|
17/04/23
|
18/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
13.7%
|
13.8%
|
12.3%
|
17.9%
|
13.8%
|
ROA (Net income/ Total Assets)
|
-
|
9.87%
|
-
|
12.2%
|
14.4%
|
-
|
Assets
1 |
-
|
2,650
|
-
|
3,555
|
4,115
|
-
|
Book Value Per Share
2 |
-
|
6.980
|
7.420
|
12.80
|
12.70
|
19.70
|
Cash Flow per Share
2 |
-
|
0.1500
|
0.8200
|
-0.2200
|
1.370
|
-0.6500
|
Capex
1 |
-
|
9.87
|
32.7
|
26.5
|
27
|
-
|
Capex / Sales
|
-
|
0.81%
|
2.37%
|
1.15%
|
0.91%
|
-
|
Announcement Date
|
28/04/22
|
17/04/23
|
18/04/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -11.71% | 927M | | +1.69% | 12.8B | | -7.57% | 7.61B | | +3.22% | 5.41B | | +0.93% | 4.51B | | +8.48% | 4.49B | | +9.21% | 2.73B | | -13.87% | 2.02B | | -11.63% | 1.73B | | +3.45% | 1.64B |
Diagnostic & Testing Substances
|